Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Working Capital Changes (2016 - 2026)

Neuroone Medical Technologies filings provide 9 years of Other Working Capital Changes readings, the most recent being $129189.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes rose 866.4% to $129189.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $75649.0, a 19.86% decrease, with the full-year FY2025 number at -$75089.0, down 58.8% from a year prior.
  • Other Working Capital Changes hit $129189.0 in Q1 2026 for Neuroone Medical Technologies, up from $13155.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q1 2023 to a low of -$1.5 million in Q4 2022.
  • Median Other Working Capital Changes over the past 5 years was $13155.0 (2025), compared with a mean of $95965.6.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 10561.5% in 2022 and later skyrocketed 66719.23% in 2023.
  • Neuroone Medical Technologies' Other Working Capital Changes stood at -$1.5 million in 2022, then soared by 99.74% to -$3780.0 in 2023, then plummeted by 475.71% to -$21762.0 in 2024, then soared by 160.45% to $13155.0 in 2025, then soared by 882.05% to $129189.0 in 2026.
  • The last three reported values for Other Working Capital Changes were $129189.0 (Q1 2026), $13155.0 (Q4 2025), and -$91991.0 (Q3 2025) per Business Quant data.